Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa

Abstract

Our study found that antiviral treatment of HBV infection was associated with longer survival in HCC. Furthermore, Sorafenib seemed beneficial in patients that used this modality and NLR was a good prognostic factor.